Global law firm Greenberg Traurig, P.A. advised Berenson Acquisition Corp. I (BACA), a special purpose acquisition corporation, in its definitive business combination agreement with Custom Health Inc., a digital health care firm. As a result of the business combination, Custom Health is expected to become a publicly listed company on the NYSE.
Custom Health, which provides comprehensive technology-enabled medication management and managed care solutions, focuses on serving poly-med patients with chronic conditions. The proposed transaction implies a $185 million pre-money equity value for Custom Health, according to the company’s press release. Proceeds from the business combination and related financing are expected to be used to fuel organic growth and future acquisitions, the company said.
Greenberg Traurig’s team was led by Miami Shareholder and Co-Chair of the firm’s Global Corporate Practice Alan I. Annex and New York Corporate Shareholders Yuta N. Delarck and Adam S. Namoury. The transaction team also included New York Corporate Associates Ricardo Crispim Leite, Yoojin Lee, and Dayoung (Taylor) Park, and Northern Virginia Corporate Associate Yangyang Jia.
Original source can be found here.